Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis

The Australasian Journal of Dermatology
Yee J TaiRobert I Kelly

Abstract

A retrospective analysis was conducted on 93 adult patients with cutaneous leukocytoclastic vasculitis from St. Vincent's Hospital Melbourne to determine the classification, aetiology, severity and prognosis of this population of patients. We developed a new classification system for the purposes of our study based on modifications to the Chapel Hill Consensus Conference definitions for vasculitic syndromes. The results of our study indicate that an obvious cause was not found in 44.1% of patients. Of the patients with secondary vasculitis, the commonest causes were drugs and infections, accounting for a total of 40.9% of patients. Extracutaneous involvement was found in 39.8% of patients. Patients with symptoms resolving in less than 3 months accounted for 59.1% of the population, whereas 24.8% of patients had either symptoms lasting three or more months or evidence of recurrent symptomatology. There were 6 deaths (6.91%) and the rest were lost to follow up. The majority of patients in this retrospective series were classified as having hypersensitivity vasculitis, which is a relatively benign disorder limited mostly to skin with a low incidence of extracutaneous involvement (15.8%). Nevertheless, evidence of systemic involvem...Continue Reading

References

Oct 1, 1991·Seminars in Arthritis and Rheumatism·Y Ilan, Y Naparstek
Feb 1, 1990·Mayo Clinic Proceedings·L E Gibson
Oct 1, 1995·British Journal of Rheumatology·S J Jessop
Oct 1, 1994·British Journal of Rheumatology·D G Scott, R A Watts
Jul 1, 1994·Archives of Dermatology·C J JennetteR J Falk
Feb 1, 1994·Arthritis and Rheumatism·J C JennetteC G Kallenberg
Jul 1, 1996·International Journal of Dermatology·T LottiI Ghersetich
Nov 20, 1997·The New England Journal of Medicine·J C Jennette, R J Falk
Nov 12, 1998·Journal of the American Academy of Dermatology·T LottiJ L Jorizzo
Jan 10, 2001·Current Opinion in Rheumatology·J H Stone, H C Nousari
Apr 23, 2002·The British Journal of Dermatology·A BauzáM Idoate
Mar 15, 2003·Journal of the American Academy of Dermatology·David F Fiorentino
Dec 18, 2004·Current Opinion in Rheumatology·Miguel A Gonzalez-GayRamon M Pujol

❮ Previous
Next ❯

Citations

Jul 9, 2013·Current Allergy and Asthma Reports·Trinitario PinaMiguel A González-Gay
Mar 3, 2012·The Indian Journal of Medical Research·Pooja KhetanManoj K Singh
Sep 11, 2012·Autoimmunity Reviews·Angelo V MarzanoEmilio Berti
Sep 27, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·M D HermidaH N Cabrera
Jan 9, 2010·Histopathology·J Andrew Carlson
Jul 15, 2015·SpringerPlus·Prasanta Kumar BhattacharyaJaya Mishra
Sep 1, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·E F JohnsonM M Tollefson
Aug 21, 2018·Vascular and Endovascular Surgery·Vikram PuramNedaa Skeik
Dec 7, 2007·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Nawaf Al-Mutairi
Apr 25, 2015·JAAPA : Official Journal of the American Academy of Physician Assistants·Michael D Overcash
Jan 25, 2020·Jornal Vascular Brasileiro·Alexandre Sacchetti BezerraJoão Antônio Corrêa
Mar 14, 2012·British Journal of Hospital Medicine·B H Millette, A K Chatterjee
Apr 21, 2020·Anais Brasileiros De Dermatologia·Thâmara Cristiane Alves Batista MoritaPaulo Ricardo Criado
Feb 19, 2021·Clinical Case Reports·Fariba IrajiSafoura Bokaei Jazi
Jul 2, 2021·Current Rheumatology Reports·Joana Martins-MartinhoCristina Ponte

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Dermatopathology
J Andrew Carlson, Ko-Ron Chen
Journal of the American Academy of Dermatology
T LottiJ L Jorizzo
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
Nawaf Al-Mutairi
© 2022 Meta ULC. All rights reserved